Spirometer guided chest imaging in children: It is worth the effort!-Reference-Cited by-同舟云学术

Spirometer guided chest imaging in children: It is worth the effort!

Published:2016-06-06 Issue:1 Volume:52 Page:48-56
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Salamon Elizabeth¹,Lever Sandra¹,Kuo Wieying¹²,Ciet Pierluigi¹²,Tiddens Harm A.W.M¹²

Affiliation:

1. Department of Pediatric Pulmonology; Erasmus Medical Center; Sophia Children's Hospital; Dr. Molewaterplein 60, Room SP-3464 3015 GJ Rotterdam The Netherlands

2. Department of Radiology; Erasmus Medical Center; Dr. Molewaterplein 60, Room SP-3464 3015 GJ Rotterdam The Netherlands

Funder

Cystic Fibrosis Foundation

Roche

Pharmaxis

Novartis

Vertex

Gilead Sciences

Vrienden van het Sophia

Sporten voor Sophia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference39 articles.

1. Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease;Eichinger;J Magn Reson Imaging,2010

2. Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography;Tiddens;Paediatr Respir Rev,2014

3. What did we learn from two decades of chest computed tomography in cystic fibrosis;Tiddens;Pediatr Radiol,2014

4. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening;Sly;Am J Respir Crit Care Med,2009

5. Novel outcome measures for clinical trials in cystic fibrosis;Tiddens;Pediatr Pulmonol,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Children with severe asthma have substantial structural airway changes on computed tomography;ERJ Open Research;2023-12-07

2. Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial;American Journal of Respiratory and Critical Care Medicine;2023-11-01

3. The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting;Respiratory Research;2023-08-11

4. Implementation and evaluation of ultra-low dose CT in early cystic fibrosis lung disease;European Respiratory Journal;2023-06-29

5. Magnetic Resonance Imaging of Pediatric Lungs and Airways;Journal of Thoracic Imaging;2023-03-31